What is Outset Medical, Inc.'s market cap?

Outset Medical, Inc. (OM) has a market capitalization of $80.1M and trades on NASDAQ.

What is Outset Medical, Inc.'s revenue and profitability?

Outset Medical, Inc. generated $117.6M in trailing twelve-month revenue with a net loss of $74.8M, representing a net margin of -63.7%. Gross margin stands at 40.6%, with free cash flow of -$34.2M. These figures are based on the Q1 2026 filing.

Who are Outset Medical, Inc.'s competitors?

Outset Medical, Inc.'s key competitors include DaVita, Inc., Baxter International Inc., Medtronic plc, and others. These companies compete in similar markets and product categories.

Who does Outset Medical, Inc. partner with?

Outset Medical, Inc.'s notable partners include TACNA Services, Infus Medical Co. Ltd..

Where is Outset Medical, Inc. headquartered?

Outset Medical, Inc. is headquartered in United States of America and employs approximately 480 people. It has been publicly traded since 2020.

Outset Medical, Inc.

Market cap

$80.08M-73.3%

Revenue$117.6M+2.0%

Net income-$74.8M+34.2%

Free cash flow-$34.2M+64.6%

EPS (diluted)-$4.07+85.9%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$27.9MMiss by $1.0M EPS-$0.83Miss by $0.04

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$29.0M

EPS estimate-$0.72

Financials

Q1 2026

Income statement

See full

Revenue$27.9M-6.3%

Gross profit$12.1M+9.3%

Operating income-$16.9M-3.2%

Net income-$19.0M+26.4%

EPS (diluted)-$1.03+71.9%

Balance sheet

See full

Cash & equivalents$30.6M-59.7%

Total debt$101.6M+3.5%

Total equity$111.7M-34.3%

Total assets$249.5M-17.2%

Cash flow

See full

Operating cash flow-$12.8M+50.0%

CapEx$65.0K-47.2%

Free cash flow-$12.9M+49.9%

Valuation & ratios

Valuation

See full

Market cap$80.08M-73.3%

Enterprise value$151.13M-60.1%

P/S0.7×-2.0×

Profitability

See full

Gross margin40.6%+4.7pp

Operating margin-57.2%-12.9pp

Net margin-63.7%-16.7pp

FCF margin-29.1%-11.5pp

Returns & leverage

See full

Return on equity-53.2%-14.8pp

Debt / equity0.9×+0.3×

Current ratio6.3×-2.1×

Segments

By product

See full

Consumables Product$13.2M-7.2%

Service And Other Revenue$9.3M+10.1%

Consoles Product$5.4M-24.2%

Competitors

By market cap

Medtronic$107.81B-8.5%

DaVita$15.2B+38.1%

Baxter International$12.1B-17.6%

Haemonetics$3.6B+1.2%

ARD

Ardent Health Partners$1.6B+2.9%

InfuSystem Holdings$188.9M+52.6%

Outset Medical, Inc.$80.1M-75.0%

Rockwell Medical$27.6M-21.7%

By revenue growth

Medtronic+8.4%

ARD

Ardent Health Partners+6.7%

DaVita+6.7%

Baxter International+5.1%

InfuSystem Holdings+3.5%

Outset Medical, Inc.+2.0%

Haemonetics-2.0%

By net margin

Haemonetics13.31%—

Medtronic13.2%-0.7pp

DaVita5.65%-1.0pp

InfuSystem Holdings5.56%+3.2pp

ARD

Ardent Health Partners2.09%-1.6pp

Baxter International-9.7%-4.5pp

Outset Medical, Inc.-63.65%+35.1pp

Profile

Outset Medical is a medical technology company that develops and manufactures the Tablo Hemodialysis System, a single enterprise solution designed to simplify dialysis delivery across the continuum of care. The company's core value proposition lies in reducing the cost and complexity of dialysis by integrating water purification and on-demand dialysate production into a compact, cloud-connected console. This technology enables providers to insource dialysis services in acute settings and allows patients to perform self-care in home environments with minimal infrastructure requirements.

Competitive position

A pioneer in compact, all-in-one dialysis technology that challenges traditional, infrastructure-heavy dialysis machines and outsourced service models.

GeographiesUnited States, Mexico

Customer segmentsHospitals, Healthcare Providers, Patients

Business modelRazor-and-blade, Capital equipment sales, Consumables, Software-as-a-Service (SaaS)

SuppliersElectronic component suppliers, Pump and motor manufacturers, Plastic tubing and concentrate suppliers, Contract manufacturers in Thailand

CustomersAcute care hospitals, Dialysis clinics, Home-based patients, Post-acute care providers

CountryUnited States of America

Listed2020

Employees480.0

CEOLeslie L. Trigg

SectorHealthcare

IndustryMedical - Devices

Websiteoutsetmedical.com

FilingsSEC EDGAR

Ask your AI about Outset Medical, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Outset Medical, Inc.'s market cap?: Outset Medical, Inc. (OM) has a market capitalization of $80.1M and trades on NASDAQ.
What is Outset Medical, Inc.'s revenue and profitability?: Outset Medical, Inc. generated $117.6M in trailing twelve-month revenue with a net loss of $74.8M, representing a net margin of -63.7%. Gross margin stands at 40.6%, with free cash flow of -$34.2M. These figures are based on the Q1 2026 filing.
Who are Outset Medical, Inc.'s competitors?: Outset Medical, Inc.'s key competitors include DaVita, Inc., Baxter International Inc., Medtronic plc, and others. These companies compete in similar markets and product categories.
Who does Outset Medical, Inc. partner with?: Outset Medical, Inc.'s notable partners include TACNA Services, Infus Medical Co. Ltd..
Where is Outset Medical, Inc. headquartered?: Outset Medical, Inc. is headquartered in United States of America and employs approximately 480 people. It has been publicly traded since 2020.